EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Inactive Matrix Gla Protein and Cardiovascular Outcomes: The Multi‐Ethnic Study of Atherosclerosis

Ashley A Berlot iD, Xueyan Fu, M Kyla Shea, Russell Tracy iD, Matthew Budoff iD, Ryung S Kim iD, Mahim Naveed iD, Sarah L Booth iD, Jorge R Kizer iD, Anna E Bortnick iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.036459 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Ashley A Berlot und 9 weiteren Autor:innen. Beteiligte Einrichtung: Albert Einstein College of Medicine Bronx NY USA. Hauptthemen laut MEDLINE: Extracellular Matrix Proteins, Calcium-Binding Proteins, Atherosclerosis, Cardiovascular Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NHLBI NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

MGP (matrix Gla protein) inhibits arterial calcification. Higher inactive MGP, in its dephosphorylated‐uncarboxylated (dp‐uc) form, is positively associated with vascular calcification, possibly portending adverse cardiovascular events. The objective of this study was to determine the association of dp‐ucMGP with incident cardiovascular disease (CVD) events and mortality in MESA (Multi‐Ethnic Study of Atherosclerosis).

Methods

MESA is a prospective cohort study of 45‐ to 84‐year‐old individuals enrolled between 2000 and 2002 with adjudicated outcomes through 2019. Dp‐ucMGP was measured at baseline in n=2663 participants with cardiac computed tomography at Exams 1 (2000–2002) and 5 (2010–2012). Age‐stratified Cox proportional hazard models were used to assess dp‐ucMGP with risk of all CVD (mean follow‐up 16±4 years), hard CVD (17±3 years), hard coronary heart disease (17±3 years), and all‐cause mortality (18±2 years).

Results

The youngest age quartile (45‐ to 53‐years‐old) with higher dp‐ucMGP levels (520–2934 pmol/L) had an increased risk of all CVD (hazard ratio [HR], 3.05 [95% CI, 1.58–5.90], P =0.001), hard CVD (HR, 2.85 [95% CI, 1.30–6.23], P =0.009), hard coronary heart disease (HR, 3.79 [95% CI, 1.31–10.95], P =0.014), and all‐cause mortality (HR, 2.73 [95% CI, 1.19–6.30], P =0.018) compared with those with dp‐ucMGP levels between 150 and 519 pmol/L in maximally adjusted models.

Conclusions

Younger individuals 45 to 53 years old with elevated dp‐ucMGP levels (≥520 pmol/L) had an increased risk of incident CVD, coronary heart disease, and all‐cause mortality. No association was seen in older adults. Additional studies are needed to better delineate the relationship of inactive MGP with incident CVD, coronary heart disease, and all‐cause mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular Matrix ProteinsCalcium-Binding ProteinsAtherosclerosisCardiovascular DiseasesHumansMatrix Gla ProteinMaleFemaleMiddle AgedAgedAged, 80 and overProspective StudiesUnited StatesBiomarkersRisk FactorsIncidenceRisk AssessmentVascular Calcification

Stichwörter der Autor:innen

cardiovascular diseaseeventsmatrix Gla

Substanzen

Matrix Gla ProteinExtracellular Matrix ProteinsCalcium-Binding ProteinsBiomarkers

Autor:innen und Institutionen

  • Albert Einstein College of Medicine Bronx NY USA.
  • Department of Medicine Beth Israel Deaconess Medical Center Boston MA USA.
  • Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University Boston MA USA.
  • University of Vermont Larner College of Medicine Burlington VA USA.
  • Division of Cardiology The Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center Torrance CA USA.
  • Department of Epidemiology and Population Health Albert Einstein College of Medicine Bronx NY USA.

ORCID-Profile: Ashley A Berlot, Russell Tracy, Matthew Budoff, Ryung S Kim, Mahim Naveed, Sarah L Booth, Jorge R Kizer, Anna E Bortnick

Förderung

  • NCATS NIH HHS
  • NHLBI NIH HHS
  • NIMH NIH HHS
  • NLM NIH HHS
  • BLRD VA
  • ORD VA
  • AHRQ HHS
  • NIDDK NIH HHS

Zitieren

APA

Berlot, A. A., Fu, X., Shea, M. K., Tracy, R., Budoff, M., Kim, R. S., Naveed, M., Booth, S. L., Kizer, J. R., & Bortnick, A. E. (2025). Inactive Matrix Gla Protein and Cardiovascular Outcomes: The Multi‐Ethnic Study of Atherosclerosis. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.036459

Vancouver

Berlot AA, Fu X, Shea MK, Tracy R, Budoff M, Kim RS, et al. Inactive Matrix Gla Protein and Cardiovascular Outcomes: The Multi‐Ethnic Study of Atherosclerosis. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.036459

BibTeX
@article{Berlot2025,
  author = {Berlot, Ashley A and Fu, Xueyan and Shea, M Kyla and Tracy, Russell and Budoff, Matthew and Kim, Ryung S and Naveed, Mahim and Booth, Sarah L and Kizer, Jorge R and Bortnick, Anna E},
  title = {Inactive Matrix Gla Protein and Cardiovascular Outcomes: The Multi‐Ethnic Study of Atherosclerosis},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.036459}
}
Kostenlos starten →